Taken together, our results indicate that hUCB-MSCs suppress the NLRP3 inflammasome in macrophages through an IL-1β feedback loop, suggesting that the therapeutic effect of hUCB-MSCs in RA may arise from the regulation of multiple macrophage functions by targeting various cytokines simultaneously. This evidence concerns the gene IL1B and rheumatoid arthritis.